• KOL
    • Necrotizing Encephalopathy
    • Favorable Outcomes With...
    • Favorable outcomes with early interleukin-6 receptor blockade in severe acute necrotizing encephalopathy of childhood: Influence Statistics

      Expert Impact

      Concepts for whichthey havehas direct influence:Necrotizing encephalopathy,Severe disability,Acute necrotizing,Encephalopathy childhood,Intravenous methylprednisolone,Acute hemorrhagic,Encephalopathy patients,Publication antibodies.

      Key People For Necrotizing Encephalopathy

      Top KOLs in the world
      #1
      Masashi Mizuguchi
      acute encephalopathy tuberous sclerosis sequence analysis
      #2
      Shigehiko Kamoshita
      p53 gene z65 cells early extubation
      #3
      K Yoshida
      situ hybridization myeloid leukemia testicular volume
      #4
      Tatsuhiro Yamanaka
      paf acetylhydrolase globoid cell united kingdom
      #5
      S Noma
      pulmonary tuberculosis c127 cells apical hypertrophy
      #6
      J Abe
      melanoma antigens large cyst cell growth

      Favorable outcomes with early interleukin-6 receptor blockade in severe acute necrotizing encephalopathy of childhood

      Abstract

      BACKGROUND: Outcome in severe acute necrotizing encephalopathy of childhood is poor, with high mortality (30%) and moderate to severe disability in survivors despite the use of intravenous corticosteroids or immunoglobulins. Increased blood interleukin 6 level correlates with poor outcome.

      METHODS: We report the early use of tocilizumab, a monoclonal antibody against the interleukin 6 receptor, in three patients (aged five, eight, and 10 years) with severe acute necrotizing encephalopathy.

      RESULTS: All three patients experienced a rapid neurological deterioration associated with febrile viral illnesses and met criteria for severe acute necrotizing encephalopathy with a high risk for death or severe disability. Intravenous methylprednisolone and tocilizumab were administered at 18 to 32 hours of encephalopathy in addition to supportive medical therapy. No side effects were observed with this therapeutic strategy. The two patients with influenza A(H1N1)pdm09 virus-related acute necrotizing encephalopathy had a short illness with excellent clinical and radiological recovery. The patient with influenza B virus-related acute necrotizing encephalopathy and florid hemorrhagic brain lesions had a slow recovery with eventual mild disability despite focal encephalomalacia on follow-up neuroimaging.

      CONCLUSIONS: The early use of interleukin 6 blockade in acute necrotizing encephalopathy is safe and may have a role in improving outcomes and preventing disability.

      Sign-in to see all concepts, it's free!

       

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.